Peter R Williamson
Overview
Explore the profile of Peter R Williamson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
123
Citations
9334
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shah S, Lai J, Basuli F, Martinez-Orengo N, Patel R, Turner M, et al.
Sci Transl Med
. 2024 Aug;
16(760):eadl5934.
PMID: 39141701
The global incidence of invasive fungal infections (IFIs) has increased over the past few decades, mainly in immunocompromised patients, and is associated with high mortality and morbidity. is one of...
2.
Bennett J, Williamson P
J Infect Dis
. 2024 Jul;
230(5):1291-1296.
PMID: 38986025
Follow-up of previously healthy patients surviving cryptococcal meningitis found that cryptococcal antigen could be detected for >1 year in serum from 38 of 44 (86%) patients and in cerebrospinal fluid...
3.
Meya D, Williamson P
N Engl J Med
. 2024 May;
390(17):1597-1610.
PMID: 38692293
No abstract available.
4.
Hargarten J, Ssebambulidde K, Anjum S, Vaughan M, Xu J, Song B, et al.
medRxiv
. 2024 Jan;
PMID: 38293201
Post-infection inflammatory syndromes have been increasingly recognized as a cause of host damage in a variety of infectious diseases including tuberculosis, bacterial meningitis, and COVID-19. Recently, a post-infectious inflammatory response...
5.
Hargarten J, Vaughan M, Lampe A, Jones R, Ssebambulidde K, Nickerson K, et al.
Infect Immun
. 2023 Nov;
91(12):e0038423.
PMID: 37975682
c is a lifelong member of the mycobiome causing mucosal candidiasis and life-threatening, systemic, and intra-abdominal disease in immunocompromised and transplant patients. Despite the clinical importance of intra-abdominal candidiasis with...
6.
Hargarten J, Anjum S, Ssebambulidde K, Park Y, Vaughan M, Scott T, et al.
J Clin Immunol
. 2023 Oct;
43(8):2146-2155.
PMID: 37814084
Purpose: Non-HIV cryptococcal meningoencephalitis (CM) in previously healthy individuals is often complicated by a post-infectious inflammatory response syndrome (c-PIIRS) characterized by neurologic deterioration after appropriate antifungal therapy with sterilization of...
7.
Boulware D, Atukunda M, Kagimu E, Musubire A, Akampurira A, Tugume L, et al.
Clin Infect Dis
. 2023 Aug;
77(12):1659-1667.
PMID: 37606364
Background: Amphotericin B is the gold standard treatment for severe mycoses. A new orally delivered, less-toxic formulation of amphotericin has been developed. Methods: In our randomized clinical trial, we tested...
8.
Hargarten J, Hu G, Elsegeiny W, Williamson P
Autophagy
. 2023 Jun;
19(10):2789-2799.
PMID: 37335017
Macroautophagy/autophagy is a regulated cellular degradation process essential as a pro-survival mechanism and integral to the regulation of diverse cellular processes in eukaryotes. During cellular stress and nutrient sensing, SQSTM1/p62...
9.
El-Atoum M, Hargarten J, Park Y, Ssebambulidde K, Ding L, Chittiboina P, et al.
BMC Infect Dis
. 2023 Jun;
23(1):407.
PMID: 37316806
Cryptococcal meningoencephalitis can occur in both previously healthy and immunocompromised hosts. Here, we describe a 55 year-old HIV-negative male with no known prior medical problems, who presented with three months...
10.
Anjum S, Bennett J, Dean O, Marr K, Hammoud D, Williamson P
J Fungi (Basel)
. 2023 May;
9(5).
PMID: 37233305
Background: A clearer understanding is needed about the use of brain MRI in non-HIV patients with cryptococcal meningitis. Methods: Cerebral CT and MRI were studied in 62 patients in a...